Rachael Thomson

Rachael Thomson

Auto-generated profile, based on publicly available information

Rachael Thomson

Centre for Tuberculosis Research, Liverpool School of Tropical Medicine, Liverpool, UK

Research Focus & Metrics

Academic Career Length

23Years (2004-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
8 January 2015 in Implementation Science
Verified
Journal Article
Open access
PDF file
EGElvis Gama
Elvis Gama
JMJason Madan
Jason Madan
HBHastings Banda
Hastings Banda
BSBertie Squire
Bertie Squire
RTRachael Thomson
Rachael Thomson
INIreen Namakhoma
Ireen Namakhoma
Chronic airway diseases pose a big challenge to health systems in most developing countries, particularly in Sub-Saharan Africa. A diagnosis for people with chronic or persistent cough is usually delayed because of individual and health system barriers. However, delayed diagnosis and treatment facilitates further transmission, severity of disease with complications and mortality. The objective of this study is to assess the cost-effectiveness of the practical approach to lung health strategy, a patient-centred approach for diagnosis and treatment of common respiratory illnesses in primary healthcare settings, as a means of strengthening health systems to improve the quality of management of respiratory diseases. Economic evaluation nested in a cluster randomised controlled trial with three arms will be performed. Measures of effectiveness and costs for all arms of the study will be obtained from the cluster randomised controlled clinical trial. The main outcome measures are a combined rate of major respiratory diseases milestones and process indicators extracted from the practical approach to lung health strategy. For analysis, descriptive as well as regression techniques will be used. A cost-effectiveness analysis will be performed according to intention-to-treat principle and from a societal perspective. Cost-effectiveness ratios will be calculated using bootstrapping techniques. We hope to demonstrate the cost-effectiveness of the practical approach to lung health and informal healthcare providers, see an improvement in patients’ quality of life, achieve a reduction in the duration and occurrence of episodes and the chronicity of respiratory diseases, and are able to report a decrease in the social cost. If the practical approach to lung health and informal healthcare provider’s interventions are cost-effective, they could be scaled up to all primary healthcare centres. PACTR: PACTR201411000910192

1 May 2004 in The Lancet Infectious Diseases
Verified
Journal Article
Closed access
IBImelda Bates
Imelda Bates
CFCaroline Fenton
Caroline Fenton
JGJanet Gruber
Janet Gruber
DLDavid Lalloo
David Lalloo
ALAntonieta Medina Lara
Antonieta Medina Lara
RTRachel Tolhurst
Rachel Tolhurst

18 December 2020 in Thorax
Verified
Journal Article
Open access
PDF file
JMJamilah Meghji
Jamilah Meghji
SGStefanie Gregorius
Stefanie Gregorius
JMJason Madan
Jason Madan
FCFatima Chitimbe
Fatima Chitimbe
RTRachael Thomson
Rachael Thomson
SSStephen Bertel Squire
Stephen Bertel Squire
Background Mitigating the socioeconomic impact of tuberculosis (TB) is key to the WHO End TB Strategy. However, little known about socioeconomic well-being beyond TB-treatment completion. In this mixed-methods study, we describe socioeconomic outcomes after TB-disease in urban Blantyre, Malawi, and explore pathways and barriers to financial recovery. Methods Adults ≥15 years successfully completing treatment for a first episode of pulmonary TB under the National TB Control Programme were prospectively followed up for 12 months. Socioeconomic, income, occupation, health seeking and cost data were collected. Determinants and impacts of ongoing financial hardship were explored through illness narrative interviews with purposively selected participants. Results 405 participants were recruited from February 2016 to April 2017. Median age was 35 years (IQR: 28–41), 67.9% (275/405) were male, and 60.6% (244/405) were HIV-positive. Employment and incomes were lowest at TB-treatment completion, with limited recovery in the following year: fewer people were in paid work (63.0% (232/368) vs 72.4% (293/405), p=0.006), median incomes were lower (US$44.13 (IQR: US$0–US$106.15) vs US$72.20 (IQR: US$26.71–US$173.29), p<0.001), and more patients were living in poverty (earning <US$1.90/day: 57.7% (211/366) vs 41.6% (166/399), p<0.001) 1 year after TB-treatment completion compared with before TB-disease onset. Half of the participants (50.5%, 184/368) reported ongoing dissaving (use of savings, selling assets, borrowing money) and 9.5% (35/368) reported school interruptions in the year after TB-treatment completion. Twenty-one participants completed in-depth interviews. Reported barriers to economic recovery included financial insecurity, challenges rebuilding business relationships, residual physical morbidity and stigma. Conclusions TB-affected households remain economically vulnerable even after TB-treatment completion, with limited recovery in income and employment, persistent financial strain requiring dissaving, and ongoing school interruptions. Measures of the economic impact of TB disease should include the post-TB period. Interventions to protect the long-term health and livelihoods of TB survivors must be explored.

1 June 2004 in The Lancet Infectious Diseases
Verified
Journal Article
Closed access
IBImelda Bates
Imelda Bates
CFCaroline Fenton
Caroline Fenton
JGJanet Gruber
Janet Gruber
DLDavid Lalloo
David Lalloo
ALAntonieta Medina Lara
Antonieta Medina Lara
RTRachel Tolhurst
Rachel Tolhurst

11 January 2021 in BMJ Global Health
Verified
Journal Article
Open access
PDF file
AFArmelle Forrer
Armelle Forrer
SWSamuel Wanji
Samuel Wanji
EOElisabeth Dibando Obie
Elisabeth Dibando Obie
TNTheobald Mue Nji
Theobald Mue Nji
LHLouise Hamill
Louise Hamill
MTMark J Taylor
Mark J Taylor
Introduction Onchocerciasis is targeted for elimination mainly with annual community-directed treatment with ivermectin (CDTI). High infection levels have been reported in South-West Cameroon, despite ≥15 years of CDTI. The aim of this study was to assess factors associated with continued onchocerciasis transmission and skin disease. Methods A large-scale cross-sectional study was conducted in 2017 in 20 communities in a loiasis-risk area in South-West Cameroon. A mixed-methods approach was used. Associations between infection levels, skin disease and adherence to CDTI were assessed using mixed regression modelling. Different community members’ perception and acceptability of the CDTI strategy was explored using semi-structured interviews. Results Onchocerciasis prevalence was 44.4% among 9456 participants. 17.5% of adults were systematic non-adherers and 5.9% participated in ≥75% of CDTI rounds. Skin disease affected 1/10 participants, including children. Increasing self-reported adherence to CDTI was associated with lower infection levels in participants aged ≥15 years but not in children. Adherence to CDTI was positively influenced by perceived health benefits, and negatively influenced by fear of adverse events linked with economic loss. Concern of lethal adverse events was a common reason for systematic non-adherence. Conclusion CDTI alone is unlikely to achieve elimination in those high transmission areas where low participation is commonly associated with the fear of adverse events, despite the current quasi absence of high-risk levels of loiasis. Such persisting historical memories and fear of ivermectin might impact adherence to CDTI also in areas with historical presence but current absence of loiasis. Because such issues are unlikely to be tackled by CDTI adaptive measures, alternative strategies are needed for onchocerciasis elimination where negative perception of ivermectin is an entrenched barrier to community participation in programmes.

7 December 2007 in Tropical Medicine & International Health
Verified
Journal Article
Open access
PDF file
XLXiaoyun Liu
Xiaoyun Liu
RTRachael Thomson
Rachael Thomson
YGYoulong Gong
Youlong Gong
FZFengzeng Zhao
Fengzeng Zhao
SSS. Bertel Squire
S. Bertel Squire
STShenglan Tang
Shenglan Tang
Objectives To assess equity in access to tuberculosis (TB) care by estimating and comparing the direct household costs perceived by community residents with actual costs experienced by TB patients and to identify the factors influencing the financial burden of TB patients. Methods Economic study in four provinces of China by means of a survey of 889 TB patients and 2560 community residents and in‐depth interviews with key informants. Results The direct household costs for using TB health services perceived by the communities were two to five times higher than the actual costs incurred by the TB patients. Patients had to pay a substantial proportion of their annual income for TB services (12–40%), despite the fact that smear‐positive and some severe smear‐negative patients received free drugs. Repeated outpatient visits before diagnosis, over‐prescription of drugs and prolonged treatments were common. Conclusions The heavy financial burden (both perceived and real) on these patients is one of the main reasons that some TB patients fail to access and complete treatment. Pressure to generate revenue through current incentives in health‐care financing and poor competence of health workers at the village and township levels cause delay and high expenses to TB patients and ultimately impede effective TB control in China.